BHSRX
Price
$64.17
Change
+$0.09 (+0.14%)
Updated
Nov 19 closing price
Net Assets
6.58B
JNGLX
Price
$81.77
Change
-$0.17 (-0.21%)
Updated
Nov 19 closing price
Net Assets
4.95B
Interact to see
Advertisement

BHSRX vs JNGLX

Header iconBHSRX vs JNGLX Comparison
Open Charts BHSRX vs JNGLXBanner chart's image
BlackRock Health Sciences Opps R
Price$64.17
Change+$0.09 (+0.14%)
VolumeN/A
Net Assets6.58B
Janus Henderson Global Life Sciences D
Price$81.77
Change-$0.17 (-0.21%)
VolumeN/A
Net Assets4.95B
BHSRX vs JNGLX Comparison Chart in %
View a ticker or compare two or three
VS
BHSRX vs. JNGLX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHSRX is a Hold and JNGLX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BHSRX has more cash in the bank: 6.58B vs. JNGLX (4.95B). JNGLX pays higher dividends than BHSRX: JNGLX (0.31) vs BHSRX (0.02). BHSRX was incepted earlier than JNGLX: BHSRX (14 years) vs JNGLX (27 years). BHSRX (1.45) is less costly to investors than JNGLX (0.80). BHSRX is a more actively managed with annual turnover of: 43.00 vs. JNGLX (35.00). BHSRX has a lower initial minimum investment than JNGLX: BHSRX (100) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : 10.59 vs. BHSRX (-0.88). JNGLX return over 5 years is better than : 17.10 vs. BHSRX (-9.52).
BHSRXJNGLXBHSRX / JNGLX
Total Expense Ratio1.440.80180%
Annual Report Gross Expense Ratio1.450.80181%
Fund Existence14 years27 years-
Gain YTD6.42820.44531%
Front LoadN/AN/A-
Min. Initial Investment10025004%
Min. Initial Investment IRAN/AN/A-
Net Assets6.58B4.95B133%
Annual Yield % from dividends0.020.316%
Returns for 1 year-0.8810.59-8%
Returns for 3 years2.0626.678%
Returns for 5 years-9.5217.10-56%
Returns for 10 years22.6451.4044%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRJZX122.601.11
+0.91%
T. Rowe Price Growth Stock Z
LVORX17.30N/A
N/A
Lord Abbett Value Opportunities R3
RAIIX28.07N/A
N/A
Manning & Napier Rainier Intl Discv I
LCLAX55.55N/A
N/A
ClearBridge Select A
ACROX18.19N/A
N/A
ACR Opportunity Fund I Shares